FDA Requires Lower Lunesta Starting Dose

The agency has announced it will be requiring a lower starting dose for the sleep drug

The FDA has announced it will be requiring the manufacturer of Lunesta (eszopiclone), a sleep drug, to lower the current recommended starting dose on the drug’s label. According to a report from the FDA, data has shown that eszopiclone levels in some patients may be high enough the morning after use that they could impair activities that require alertness. Patients may feel fully awake but actually be impaired.

The recommended dose has been lowered from 2 mg to 1 mg for both men and women. The drug’s dose can be increased to 2 or 3 mg, though a higher dose is more likely to result in next day impairment. The change in dose comes as a result of a recent study that followed 91 healthy adults ages 25-40. The study showed that Lunesta 3 mg, when compared to a placebo pill, was associated with “severe next-morning psychomotor and memory impairment in both men and women 7.5 hours after taking the drug.”

“To help ensure patient safety, health care professionals should prescribe, and patients should take, the lowest dose of a sleep medicine that effectively treats their insomnia,” said Ellis Unger, M.D., director, Office of Drug Evaluation I in the FDA's Center for Drug Evaluation and Research, in the FDA’s press release. “Recently, data from clinical trials and other types of studies have become available, which allowed the FDA to better characterize the risk of next-morning impairment with sleep drugs.”

Current Lunesta users taking 2 or 3 mg should consult their health care professional for next step instructions. 

Download Center

HTML - No Current Item Deck
  • Safety Management Software - Free Demo

    IndustrySafe Safety Software’s comprehensive suite of modules help organizations to record and manage incidents, inspections, hazards, behavior based safety observations, and much more. Improve safety with an easy to use tool for tracking, notifying and reporting on key safety data.

  • Create Flexible Safety Dashboards

    IndustrySafe’s Dashboard Module allows organizations allows you to easily create and view safety KPIs to help you make informed business decisions. Our best of breed default indicators can also save you valuable time and effort in monitoring safety metrics.

  • Schedule and Record Observations

    IndustrySafe's Observations module allows managers, supervisors, and employees to conduct observations on employees involved in safety critical behavior. IndustrySafe’s pre-built BBS checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Why Is Near Miss Reporting Important?

    A near miss is an accident that's waiting to happen. Learn how to investigate these close calls and prevent more serious incidents from occurring in the future.

  • Get the Ultimate Guide to Safety Training

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common FAQs.

  • Industry Safe
comments powered by Disqus

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2019

    June 2019

    Featuring:

    • ASSP SAFETY 2019 PREVIEW
      New Orleans Networking
    • NATION SAFETY MONTH
      Heed These Summer Safety Tips
    • TRAINING
      Education, Skill Development, and Behavior Change
    • SAFETY MANAGEMENT
      What Good Looks Like
    View This Issue

Bulwark Quiz